What does it cost to redispense unused medications in the pharmacy? A micro-costing study

被引:19
作者
Bekker, Charlotte L. [1 ,2 ]
Gardarsdottir, Helga [2 ,3 ,4 ]
Egberts, Antoine C. G. [2 ,3 ]
Molenaar, Hendrik A. [3 ]
Bouvy, Marcel L. [3 ]
van den Bemt, Bart J. F. [1 ,4 ,5 ,6 ]
Hovels, Anke M. [3 ]
机构
[1] Sint Maartensklin, Dept Pharm, Hengstdal 3, NL-6574 NA Nijmegen, Netherlands
[2] Univ Med Ctr Utrecht, Dept Clin Pharm, Div Labs & Pharm, Heidelberglaan 100, NL-3584 CX Utrecht, Netherlands
[3] Univ Utrecht, Utrecht Inst Pharmaceut Sci, Div Pharmacoepidemiol & Clin Pharmacol, Univ Weg 99, NL-3584 CG Utrecht, Netherlands
[4] Univ Iceland, Fac Pharmaceut Sci, Saemundargata 2, IS-101 Reykjavik, Iceland
[5] Radboud Univ Nijmegen, Med Ctr, Dept Pharm, Geert Grootepl Zuid 10, NL-6525 GA Nijmegen, Netherlands
[6] Maastricht Univ, Med Ctr, Dept Clin Pharm & Toxicol, P Debyelaan 25, NL-6229 HX Maastricht, Netherlands
关键词
Micro-costing; Medication waste; Redispensing; Healthcare economics; Cost-benefit ratio; RETURNED MEDICINES; WASTE;
D O I
10.1186/s12913-019-4065-6
中图分类号
R19 [保健组织与事业(卫生事业管理)];
学科分类号
摘要
BackgroundRedispensing unused medications that have been returned to outpatient pharmacies by patients may reduce waste and healthcare costs. However, little is known regarding the extra costs associated with this process, nor the price level of medications for which this is economically beneficial. The objective of this study was to assess costs associated with redispensing unused medications in the pharmacy and the price level at which redispensing becomes cost-beneficial.MethodsA micro-costing study was conducted in four Dutch outpatient pharmacies for medications requiring room-temperature storage and requiring refrigeration. First, the pharmacy's necessary additional process steps and resources for redispensing were identified. Second, time required for each process step was simulated. Third, required resources were quantified by calculating labour, purchasing and overhead costs. Lastly, a model with different scenarios was constructed to calculate the price of a medication package at which redispensing becomes cost-beneficial.ResultsThree main additional process steps for redispensing were identified: (1) pack medications with product quality indicators before dispensing, (2)assess quality of medications returned to the pharmacy (temperature storage, package integrity, expiry date) and (3a)restock medications fulfilling quality criteria or (3b)dispose of medications not fulfilling criteria. Total time required for all steps up to restock one medication package was on average 5.3 (SD 0.3) and 6.8 (SD +/- 0.3) minutes for medications stored at room-temperature and under refrigeration, respectively, and associated costs were Euro5.54 and Euro7.61. Similar outcomes were found if a medication package would ultimately be disposed of. The price level primarily depended upon the proportion of dispensed packages returned unused to the pharmacy and fulfilling the quality criteria: if 5% is returned, of which 60% fulfils quality criteria, the price level was Euro101 per package for medications requiring room-temperature storage and Euro215 per package for those requiring refrigeration. However, if 10% is returned, of which 60% fulfils the quality criteria, the price level decreases to Euro53 and Euro109, respectively (arbitrary proportions).Conclusions Redispensing unused medications in the pharmacy is at least cost-beneficial if applied to expensive medications.
引用
收藏
页数:9
相关论文
共 29 条
  • [1] How do people conceptualise the reuse of medicines? An interview study
    Alhamad, Hamza
    Patel, Nilesh
    Donyai, Parastou
    [J]. INTERNATIONAL JOURNAL OF PHARMACY PRACTICE, 2018, 26 (03) : 232 - 241
  • [2] [Anonymous], 2012, PRESCRIBER, DOI DOI 10.1002/PSB.962
  • [3] [Anonymous], 2015, CAO PHARM
  • [4] [Anonymous], 2015, METHODS EC EVALUATI
  • [5] [Anonymous], 2015, COST GUID METH COST
  • [6] [Anonymous], 2015, GUID EC EV HEALTHC
  • [7] Patient and medication factors associated with preventable medication waste and possibilities for redispensing
    Bekker, C. L.
    van den Bemt, B. J. F.
    Egberts, A. C. G.
    Bouvy, M. L.
    Gardarsdottir, H.
    [J]. INTERNATIONAL JOURNAL OF CLINICAL PHARMACY, 2018, 40 (03) : 704 - 711
  • [8] Quantity and economic value of unused oral anti-cancer and biological disease-modifying anti-rheumatic drugs among outpatient pharmacy patients who discontinue therapy
    Bekker, C. L.
    Melis, E. J.
    Egberts, A. C. G.
    Bouvy, M. L.
    Gardarsdottir, H.
    van den Bemt, B. J. F.
    [J]. RESEARCH IN SOCIAL & ADMINISTRATIVE PHARMACY, 2019, 15 (01) : 100 - 105
  • [9] Pharmacists' Activities to Reduce Medication Waste: An International Survey
    Bekker, Charlotte L.
    Gardarsdottir, Helga
    Egberts, Antoine C. G.
    Bouvy, Marcel L.
    van den Bemt, Bart J. F.
    [J]. PHARMACY, 2018, 6 (03):
  • [10] Redispensing of medicines unused by patients: a qualitative study among stakeholders
    Bekker, Charlotte L.
    Gardarsdottir, Helga
    Egberts, Toine C. G.
    Bouvy, Marcel L.
    van den Bemt, Bart J. F.
    [J]. INTERNATIONAL JOURNAL OF CLINICAL PHARMACY, 2017, 39 (01) : 196 - 204